December 19, 2023 December 19, 2023ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
November 28, 2023 November 28, 2023Julius Clinical Research Receives Growth Investment from Ampersand Capital Partners
November 20, 2023 November 20, 2023New Capital Strengthens ProtaGene’s Advanced Analytical Leadership in the Biologics and Cell and Gene Therapy Markets
November 6, 2023 November 6, 2023Ampersand Capital Partners Named to Inc.’s 2023 List of Founder-Friendly Investors
November 2, 2023 November 2, 2023Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities
October 16, 2023 October 16, 2023P95, a leading vaccine-focused CRO, merges with South Africa-based CRO OnQ Research
